Drug Type Small molecule drug |
Synonyms 2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester, 2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester, alpha-(p-Chlorophenoxy)isobutyric acid, ethyl ester + [11] |
Target |
Mechanism PPARα agonists(Peroxisome proliferator-activated receptor α agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (08 Feb 1967), |
Regulation- |
Molecular FormulaC12H15ClO3 |
InChIKeyKNHUKKLJHYUCFP-UHFFFAOYSA-N |
CAS Registry637-07-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00279 | Clofibrate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypercholesterolemia | US | 08 Feb 1967 | |
Hyperlipidemias | US | 08 Feb 1967 | |
Hypertriglyceridemia | US | 08 Feb 1967 |